IVIg and FcgRIIb in kids with ITP: Individualizing therapy Academic Article uri icon

Overview

MeSH Major

  • Heparin
  • Thrombocytopenia

abstract

  • ¬© 2018 by The American Society of Hematology In this issue of Blood, Heitink-Poll√© et al present the long-awaited results of a very important recent study, the TIKI (treatment with or without IV immunoglobulin [IVIg] for kids with immune thrombocytopenia [ITP]) trial: a randomized, controlled trial comparing IVIg to observation in children with ITP at diagnosis, with the primary end point of evaluating the rate of chronic ITP in treated and untreated children.

publication date

  • August 30, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1182/blood-2018-07-861690

PubMed ID

  • 30166359

Additional Document Info

start page

  • 877

end page

  • 878

volume

  • 132

number

  • 9